Dr Mathilda Wilding
/content/dam/genesiscare/headshots/au-doctor-headshots/AU_Oncology_Headshot_GA_Dr_Mathilda_Whiting.jpg
Cancer Geneticist

Dr Mathilda Wilding

Dr Mathilda Wilding
Mathilda
Wilding

MBBS, FRACP (MedOnc, ClinGen), BMedSi, Cancer Geneticist

For patients/carers

For doctors

MBBS, FRACP (MedOnc, ClinGen), BMedSi, Cancer Geneticist

Locations

North Shore, NSW
North Shore
North Shore Health Hub, Tower A, Level 1, 7 Westbourne St, St Leonards, NSW, 2065, Australia
-33.82024297423824, 151.19062046149045
/au/our-centres/north-shore
NSW

Languages

Fluent

  • English

Biography

Clinical interest in cancer genetics.

Dr Mathilda Wilding has been working in the field of cancer genetics since 2015. Mathilda is qualified as a specialist in medical oncology (cancer treatment) and clinical genetics. Mathilda is one of only a few doctors in Australia to have achieved both of these qualifications, and has been appointed as a cancer genetics consultant at Royal North Shore Hospital, Sydney.

Mathilda is a Fellow of the Royal College of Physicians (FRACP) and a member of the Human Genetics Society of Australia (HGSA). She is a member of the adult and paediatric cancer genetics reference committees for the National Cancer Institute (eviQ) guidelines. She is involved in developing evidence-based genetic testing and risk management guidelines, that are used Nationally and Internationally, to guide genetic testing and the management of individuals with an inherited cause of cancer.

A dedicated teacher, she supervises and mentors training doctors and genetic counsellors from hospitals across NSW.

Mathilda aims to be a caring and respectful clinician, supporting patients with evidence-based care.

quotation mark
I am passionate about helping patients and their families better understand the importance of prevention and early diagnosis for cancer.
quotation mark

More information

Professional memberships
  • Human Genetics Society of Australia (HGSA)
  • Cancer Genetics Reference Committees for the National Cancer Institute (eviQ)
  • Fellow of Royal Australian College of Physicians (FRACP) 
Publications
  • Crook, A., Kwa, R., Ephraums, S., Wilding, M., Thiyagarajan, L., Fleming, J., ... & Berman, Y. (2021). The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1. Familial cancer, 1-13.
  • Benn, D. E., Zhu, Y., Andrews, K. A., Wilding, M., Duncan, E. L., Dwight, T., ... & Clifton-Bligh, R. J. (2018). Bayesian approach to determining penetrance of pathogenic SDH variants. Journal of medical genetics, 55(11), 729-734.